• E V Starikova, J S Galeeva, D N Andreev, P S Sokolov, D E Fedorov, A I Manolov, A V Pavlenko, K M Klimina, V A Veselovsky, A V Zaborovsky, V V Evdokimov, N G Andreev, M K Devkota, A K Fomenko, V A Khar'kovskii, P O Asadulin, S A Kucher, A S Cheremushkina, O O Yanushevich, I V Maev, N I Krikheli, O V Levchenko, E N Ilina, and V M Govorun.
• Research Institute of Systemic Biology and Medicine.
• Terapevt Arkh. 2022 Oct 12; 94 (8): 963-972.

AimTo identify features of the taxonomic composition of the oropharyngeal microbiota of COVID-19 patients with different disease severity.Materials And MethodsThe study group included 156 patients hospitalized with confirmed diagnosis of COVID-19 in the clinical medical center of Yevdokimov Moscow State University of Medicine and Dentistry between April and June 2021. There were 77 patients with mild pneumonia according to CT (CT1) and 79 patients with moderate to severe pneumonia (CT2 and CT3). Oropharyngeal swabs were taken when the patient was admitted to the hospital. Total DNA was isolated from the samples, then V3V4 regions of the 16s rRNA gene were amplified, followed by sequencing using Illumina HiSeq 2500 platform. DADA2 algorithm was used to obtain amplicon sequence variants (ASV).ResultsWhen comparing the microbial composition of the oropharynx of the patients with different forms of pneumonia, we have identified ASVs associated with the development of both mild and severe pneumonia outside hospital treatment. Based on the results obtained, ASVs associated with a lower degree of lung damage belong predominantly to the class of Gram-negative Firmicutes (Negativicutes), to various classes of Proteobacteria, as well as to the order Fusobacteria. In turn, ASVs associated with a greater degree of lung damage belong predominantly to Gram-positive classes of Firmicutes Bacilli and Clostridia. While being hospitalized, patients with severe pneumonia demonstrated negative disease dynamics during treatment significantly more often.ConclusionWe have observed differences in the taxonomic composition of the oropharyngeal microbiota in patients with different forms of pneumonia developed outside hospital treatment against COVID-19. Such differences might be due to the presumed barrier function of the oropharyngeal microbiota, which reduces the risk of virus titer increase.

12 keywords...

hide…